MGC Pharma first medicinal cannabis company to list on LSE
Filed with ASX · · 3 pages · English
Earlier from Argent Biopharma
- MGC Pharma Investor Presentation
- December Quarterly Activity and Cashflow Report
- ArtemiC Phase II Clinical Trial Results
- Prospectus
- MGC pharma completes acquisition of telehealth platform MCC
Later from Argent Biopharma
- SwissPharmaCan AG increases initial purchase order
- Ethics Committee Approval Granted Phase III Clinical Trial
- Mxc completes first ArtemiC order, March qtr record revenue
- Investor presentation
- MGC pharma to acquire medical research company MediCaNL
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma